Stay updated on LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision was bumped from v3.5.2 to v3.5.3, updating the page's metadata.
    Difference
    0.1%
    Check dated 2026-04-30T18:54:00.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.1%
    Check dated 2026-04-16T11:12:12.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T15:49:55.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 in the page footer.
    Difference
    0.1%
    Check dated 2026-03-11T14:22:29.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Updated the page to Revision 3.4.2. The government funding lapse notice and the prior Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T09:48:20.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH open status. Updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:22:27.000Z thumbnail image

Stay in the know with updates to LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.